MEWA Health Economics & Outcomes Research (HEOR) Services Market to Grow at a CAGR of 6.7% to reach US$ 34.47 million from 2022 to 2030

MEWA Health Economics & Outcomes Research (HEOR) Services Market Size and Forecast (2020-2030), Regional Share, Trends, and Growth Opportunity Analysis Coverage: By Service (Economic Modelling/Evaluation, Real-World Data Analysis and Information Systems, Clinical Outcome, and Market Access Solutions and Reimbursement), Service Provider (Consultancy and Contract Research Organization), End User (Healthcare Providers, Healthcare Payers, Biotech/Pharma Companies, and Government Organizations), and Region (Middle East & West Africa)

  • Report Code : TIPRE00030076
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 88
Buy Now

[Research Report] The MEWA health economics & outcomes research (HEOR) market size is expected to reach US$ 57.90 million by 2030 from US$ 34.47 million in 2022. The market is estimated to grow at a CAGR of 6.7% from 2022 to 2030.

Market Insights and Analyst View:

Health economics focuses on measuring and evaluating the outcomes of health interventions. Outcomes research encompasses a range of scientific disciplines that help in evaluating the impact of health interventions on patients. Therefore, health economics and outcomes research (HEOR) combines two fields to provide meaningful data and insights for healthcare decision-makers. Interest in HEOR has grown exponentially as governments and other payers grapple with how to achieve the best possible health outcomes at an affordable cost. HEOR can help healthcare decision-makers, including physicians, governments, payers, ministries of health, patients, and more, appropriately compare and select available options. The growing biotechnology & pharmaceutical companies and drug developments and increasing healthcare spending are driving the MEWA HEOR market. However, the restrictions on access to real-world data (RWD) hinder the market growth.

Growth Drivers and Challenges:

Drug development activities are being conducted constantly in the MEWA to provide quality drugs and improve lives owing to the rising chronic diseases and aging population. To drive business, there is a need for understanding the health economics and their outcomes. Thus, it becomes difficult for market players to design a product and its lifecycle throughout the developmental process. Various companies outsource health economics and outcomes research (HEOR) services to understand the regulations, healthcare coverage, and access decisions and identify the intervention that would benefit the specific population of patients. Thus, various well-established companies outsource HEOR services to save on production cost. The HEOR service providers help pharmaceutical and biotechnology companies explain the value of their innovations to their respective stakeholders, such as physicians, payers, and patients. Given the potential for economic growth and improved health outcomes, the biotechnology sector in the Middle East is attracting increasing attention and investment. Such partnerships are expected to boost the HEOR services in the Middle East. Chinese pharmaceutical companies are also entering Africa by making multibillion-dollar investments in local drug manufacturing facilities, lured by the unmet health needs of the world's fastest-growing and most developing continent. The investments by the pharmaceutical companies in the region are adding up to the market growth.

Healthcare spending in the Middle East has increased rapidly, leading to a growing demand for new and innovative healthcare solutions. According to a Dubai Chamber of Commerce report, Saudi Arabia and the UAE hold the largest market share in the biotechnology market in the Middle East and is expected to reach US$ 2.6 million by 2028. In the 2023 federal budget, the UAE allocated US$ 1.3 billion for community health care and protection. Further, different demographic characteristics and health outcomes, among others, characterize West Africa. Health systems in sub-Saharan Africa, including West Africa, have long suffered from a dual burden of communicable and noncommunicable diseases. Governments support technological developments in the health sector to improve living standards in West Africa. As a result, policies are implemented to provide quality healthcare by investing in advanced technologies such as sophisticated equipment, diagnostic items, and high-quality medicines for treatments. Investments in the health sector are encouraged as they lead to increased human capital development and well-being of the population, which in turn leads to economic growth in the region. Thus, the growing healthcare expenditure in the MEWA is positively influencing the HEOR service market growth.

The HEOR service is primarily based on analyzing RWD, and the real-world evidence (RWE) is derived. In the healthcare industry, countless research and developments are being conducted, owing to which a huge database is generated during and after the clinical research. Companies cannot store and manage data; hence, they outsource the data maintenance. Due to security and personal reasons, it becomes difficult for HEOR service providers to collect data from third-party companies and generate an RWE. In addition, access to RWD is highly regulated. The owners do not allow access to their data, so generating evidence for any new product launch and development becomes challenging. Sharing the data with payers is also restricted, which further restricts HEOR service providers from gathering vital information on the developing areas of the healthcare industry. Thus, restricted access to RWD restrains the MEWA HEOR service market growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

MEWA Health Economics & Outcomes Research (HEOR) Services Market: Strategic Insights

mewa-health-economics-outcomes-research-heor-services-market
Market Size Value inUS$ 34.47 million in 2022
Market Size Value byUS$ 57.90 million by 2030
Growth rateCAGR of 6.7% from 2022 to 2030
Forecast Period2022-2030
Base Year2022
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The “Middle East & West Africa Health Economics & Outcome Research (HEOR) Services Market” is segmented based on service, service provider, end user, and region.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

Based on service, the MEWA health economics & outcome research (HEOR) services market is segmented into clinical outcome, economic modelling/evaluation, market access solutions and reimbursement, and real-world data analysis and information systems. The clinical outcome segment held the largest market share in 2022. The real-world data analysis and information systems segment is predicted to register the highest CAGR of 7.5% during 2022–2030. Clinical outcome studies are important to understand the effect of treatment on the patient. It also studies the mortality and morbidity rate, treatment efficacy, and functioning of particular drug candidates. A clinical outcome assessment provides a quantitative rating to indicate some aspects of the patient's health status. Moreover, the outcome assessments are used to overview clinical studies comprehensively. In July 2020, Certara launched the COVID-19 clinical outcomes database worldwide to offer real-time information about COVID-19 studies. Further, the database will help determine the feasibility of potential vaccines and therapeutics for viral infection from more than 500 registered studies worldwide. Further, real-world data analysis is significantly used to fast-track drug development for rare diseases. In addition, the benefits of real-world data analysis attract pharmaceutical companies to implement the methodologies during their clinical studies. In May 2023, Komodo Health announced that its real-world evidence (RWE) technology platform is used to help 17 new health economics and outcomes research (HEOR) studies, which were presented at the global conference 2023 at International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Increasing awareness of information systems and real-world data analysis generates significant market potential. In addition, the companies are implementing various strategies to prove their existence in the global markets.

The MEWA health economics & outcome research (HEOR) services market, by service provider, is bifurcated into contract research organizations and consultancy. The contract research organizations segment held a larger market share in 2022 and is anticipated to register a higher CAGR during 2022–2030.

Contract research organizations offer support to biopharmaceutical, medical device, pharmaceutical, and biotechnology companies in terms of research services on a contract basis. In November 2022, IQVIA and Clalit Health Services partnered to advance research by launching the first Prime Site in Israel. The collaboration combines IQVIA and Clalit's clinical trial delivery, data, genomics, and real-world research capabilities. Benefits such as cost & time optimization and lower investments are estimated to positively impact the contract research organization segment growth.

The MEWA health economics & outcome research (HEOR) services market, by end user, is segmented into biotech/pharma companies, healthcare payers, government organizations, and healthcare providers. The biotech/pharma companies segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030. Biotechnology and pharmaceutical companies extensively adopt HEOR services to improve product development, market access, and economic outcomes. In addition, growing investments of the companies for product and market optimization are likely to drive segment growth.

Regional Analysis:

Based on country, the health economics & outcome research (HEOR) services market is divided Saudi Arabia, UAE, Qatar, Kuwait, and the Rest of MEWA. Saudi Arabia held the largest market share, followed by the UAE. The market growth is attributed to the growth of pharmaceutical expenditure due to rising interest in the country's economic evaluation of healthcare interventions. A sharp increase in the state health budget is also expected to increase the demand for the pharmaceutical industry. In 2019, Saudi Arabia's health budget increased by 8% compared to the previous year, amounting to US$ 46 billion. Saudi Arabia also has a large number of clinical trials in progress. The successful passing of drug candidates through clinical trials and hitting bulk production will likely create the demand for efficient manufacturing procedures such as continuous manufacturing. For instance, according to clinicaltrials.gov, in August 2018, ~121 studies were conducted in Saudi Arabia. Further, the Saudi Arabian Government also encourages the private healthcare sector to develop and deliver innovative models of care. Therefore, the factors mentioned above are driving the growth of the market in the country.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Competitive Landscape and Key Companies:

Developments in the MEWA health economics & outcome research (HEOR) services market have been characterized as organic and inorganic growth strategies. Various companies focus on organic growth strategies such as launches, expansion, enhancement, and relocation. Inorganic growth strategies witnessed in the market were mergers & acquisitions, partnership, and collaborations. These activities have paved the way for the expansion of businesses and customer base of MEWA health economics & outcome research (HEOR) services market players.

  • In April 2023, PharmaLex Group announced its intention to merge with Cpharm. The merger plays a crucial role in expanding PharmaLex’s footprint in Australia and New Zealand with the help of Cpharm’s expert capabilities in drug and device vigilance in the region, thereby offering complementary services and thus expanding the service portfolio of both companies. 
  • In March 2023, LEO Pharma and ICON plc announced a strategic partnership that enabled LEO Pharma to perform clinical trial execution that is patient-centric and cost-effective, and the partnership further supports the company’s overall ambition to build an effective and efficient clinical portfolio execution organization in the industry.
  • In March 2023, IQVIA partnered with (RED) to fight AIDS and the injustices that enable pandemics to thrive, to support laboratory system strengthening, and to save lives. This US$ 5 million impact partnership will channel life-saving money to the Global Fund’s Laboratory Systems Integration Fund.
  • In September 2021, SM Health and Optum announced a collaboration that mainly focused on making quality care more accessible and affordable for people across the Midwest. SSM Health and Optum partnered across certain functions—including inpatient care management, digital transformation, and revenue cycle management—to improve health outcomes and patients’ healthcare experiences.

Company Profiles

  • PharmaLex GmbH
  • ICON Plc
  • IQVIA Holdings Inc
  • Syneos Health Inc
  • Optum Inc
  • Value In Research
  • ExlService Holdings, Inc
  • Clarivate Plc
  • CCHO
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Service, Service Provider, End User, and Region

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in market the MEWA health economics & outcomes research (HEOR) services market?

The MEWA health economics & outcomes research (HEOR) services market majorly consists of the players such as PharmaLex GmbH, ICON Plc, IQVIA Holdings Inc, Syneos Health Inc, Optum Inc, Value In Research, ExlService Holdings, Inc, Clarivate Plc, and CCHO among others.

What are health economics & outcomes research (HEOR) services?

Health economics focuses on measuring and evaluating the outcomes of health interventions. Outcomes research encompasses a range of scientific disciplines that help in evaluating the impact of health interventions on patients. Therefore, health economics and outcomes research (HEOR) combines two fields to provide meaningful data and insights for healthcare decision-makers. Interest in HEOR has grown exponentially as governments and other payers grapple with how to achieve the best possible health outcomes at an affordable cost. HEOR can help healthcare decision-makers, including physicians, governments, payers, ministries of health, patients, and more, appropriately compare and select available options.

What are the driving and restraining factors for the MEWA health economics & outcomes research (HEOR) services market?

The factors that are driving the growing biotechnology & pharmaceutical companies and drug developments and increasing healthcare spending. On the other hand, restrictions on access to real-world data (RWD) is likely to hinder the growth of the market during the forecast period.

Which segment is dominating the MEWA health economics & outcomes research (HEOR) services market?

The MEWA health economics & outcomes research (HEOR) services market is analyzed in the basis of service, service provider, and end user. Based on service, the MEWA health economics & outcome research (HEOR) services market is segmented into clinical outcome, economic modelling/evaluation, market access solutions and reimbursement, and real-world data analysis and information systems. The clinical outcome segment held the largest market share in 2022. The real-world data analysis and information systems segment is predicted to register the highest CAGR during 2022–2030. The MEWA health economics & outcome research (HEOR) services market, by service provider, is bifurcated into contract research organizations and consultancy. The contract research organizations segment held a larger market share in 2022 and is anticipated to register a higher CAGR during 2022–2030. The MEWA health economics & outcome research (HEOR) services market, by end user, is segmented into biotech/pharma companies, healthcare payers, government organizations, and healthcare providers. The biotech/pharma companies segment held the largest market share in 2022 and is anticipated to register the highest CAGR during 2022–2030.

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. MEWA Health Economics & Outcomes Research (HEOR) Market – Market Landscape

4.1 Overview

4.1.1 MEWA PEST Analysis

5. MEWA Health Economics & Outcomes Research (HEOR) Market – Country Analysis

5.1 Key Market Drivers:

5.1.1 Growing Biotechnology & Pharmaceutical Companies and Drug Development

5.1.2 Increasing Healthcare Spending

5.2 Market Restraints

5.2.1 Restrictions on Access to Real-World Data (RWD)

5.3 Market Opportunities

5.3.1 Emergence of Precision Medicines

5.4 Future Trends

5.4.1 Digitalization in Healthcare

5.5 Impact Analysis:

6. MEWA Health Economics & Outcomes Research (HEOR) Market – Country Analysis

6.1 MEWA Health Economics & Outcomes Research (HEOR) Market Revenue Forecast and Analysis

7. MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 – by Service

7.1 Overview

7.2 MEWA Health Economics & Outcomes Research (HEOR) Market Revenue Share, by Service 2022 & 2030 (%)

7.3 Clinical Outcome

7.3.1 Overview

7.3.2 Clinical Outcome: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

7.4 Economic Modelling/Evaluation

7.4.1 Overview

7.4.2 Economic Modelling/Evaluation: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

7.5 Market Access Solutions and Reimbursement

7.5.1 Overview

7.5.2 Market Access Solutions and Reimbursement: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

7.6 Real-World Data Analysis and Information Systems

7.6.1 Overview

7.6.2 Real-World Data Analysis and Information Systems: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

8. MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 – By Service Provider

8.1 Overview

8.2 MEWA Health Economics & Outcomes Research (HEOR) Market Revenue Share, By Service Provider 2022 & 2030 (%)

8.3 Contract Research Organizations

8.3.1 Overview

8.3.2 Contract Research Organizations: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

8.4 Consultancy

8.4.1 Overview

8.4.2 Consultancy: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

9. MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 – By End User

9.1 Overview

9.2 MEWA Health Economics & Outcomes Research (HEOR) Market Revenue Share, By End User 2022 & 2030 (%)

9.3 Biotech/Pharma Companies

9.3.1 Overview

9.3.2 Biotech/Pharma Companies: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

9.4 Healthcare Payers

9.4.1 Overview

9.4.2 Healthcare Payers: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

9.5 Government Organizations

9.5.1 Overview

9.5.2 Government Organizations: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

9.6 Healthcare Providers

9.6.1 Overview

9.6.2 Healthcare Providers: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

10. MEWA Health economics & outcomes research (HEOR) Market – Revenue and Forecast to 2030 – Country Analysis

10.1 MEWA: Health Economics & Outcomes Research (HEOR) Market Revenue and Forecast to 2030

10.1.1 Overview

10.1.1.1 MEWA: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (USD Million)

10.1.2 MEWA: Health Economics & Outcomes Research (HEOR) Market, by Service, 2030 (USD Million)

10.1.3 MEWA: Health Economics & Outcomes Research (HEOR) Market, by Service Provider, 2030 (USD Million)

10.1.4 MEWA: Health Economics & Outcomes Research (HEOR) Market, by End User, 2030 (USD Million)

10.1.5 MEWA: Health Economics & Outcomes Research (HEOR) Market, by Country, 2022 & 2030 (%)

10.1.5.1 Saudi Arabia

10.1.5.1.1 Overview

10.1.5.1.2 Saudi Arabia: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

10.1.5.1.3 Saudi Arabia: Health Economics & Outcomes Research (HEOR) Market, by Service, 2020–2030 (US$ Million)

10.1.5.1.4 Saudi Arabia: Health Economics & Outcomes Research (HEOR) Market, by Service Provider, 2030 (USD Million)

10.1.5.1.5 Saudi Arabia: Health Economics & Outcomes Research (HEOR) Market, by End User, 2020–2030 (US$ Million)

10.1.5.2 UAE

10.1.5.2.1 Overview

10.1.5.2.2 UAE: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

10.1.5.2.3 UAE: Health Economics & Outcomes Research (HEOR) Market, by Service, 2020–2030 (US$ Million)

10.1.5.2.4 UAE: Health Economics & Outcomes Research (HEOR) Market, by Service Provider, 2030 (USD Million)

10.1.5.2.5 UAE: Health Economics & Outcomes Research (HEOR) Market, by End User, 2020–2030 (US$ Million)

10.1.5.3 Qatar

10.1.5.3.1 Overview

10.1.5.3.2 Qatar: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

10.1.5.3.3 Qatar: Health Economics & Outcomes Research (HEOR) Market, by Service, 2020–2030 (US$ Million)

10.1.5.3.4 Qatar: Health Economics & Outcomes Research (HEOR) Market, by Service Provider, 2030 (USD Million)

10.1.5.3.5 Qatar: Health Economics & Outcomes Research (HEOR) Market, by End User, 2020–2030 (US$ Million)

10.1.5.4 Kuwait

10.1.5.4.1 Overview

10.1.5.4.2 Kuwait: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

10.1.5.4.3 Kuwait: Health Economics & Outcomes Research (HEOR) Market, by Service, 2020–2030 (US$ Million)

10.1.5.4.4 Kuwait: Health Economics & Outcomes Research (HEOR) Market, by Service Provider, 2030 (USD Million)

10.1.5.4.5 Kuwait: Health Economics & Outcomes Research (HEOR) Market, by End User, 2020–2030 (US$ Million)

10.1.5.5 Rest of MEWA

10.1.5.5.1 Overview

10.1.5.5.2 Rest of MEWA: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

10.1.5.5.3 Rest of MEWA: Health Economics & Outcomes Research (HEOR) Market, by Service, 2020–2030 (US$ Million)

10.1.5.5.4 Rest of MEWA: Health Economics & Outcomes Research (HEOR) Market, by Service Provider, 2030 (USD Million)

10.1.5.5.5 Rest of MEWA: Health Economics & Outcomes Research (HEOR) Market, by End User, 2020–2030 (US$ Million)

11. MEWA Health Economics & Outcomes Research (HEOR) Market – Industry Landscape

11.1 Overview

11.1 Organic Developments

11.1.1 Overview

11.2 Inorganic Developments

11.2.1 Overview

12. Company Profiles

12.1 PharmaLex GmbH

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 ICON Plc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 IQVIA Holdings Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Syneos Health Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Optum Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Value In Research

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 ExlService Holdings, Inc.

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Clarivate Plc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 CCHO

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. MEWA Health economics & outcomes research (HEOR) Market Segmentation

Table 2. MEWA: Health Economics & Outcomes Research (HEOR) Market, by Service – Revenue and Forecast to 2030 (USD Million)

Table 3. MEWA: Health Economics & Outcomes Research (HEOR) Market, by Service Provider – Revenue and Forecast to 2030 (USD Million)

Table 4. MEWA: Health Economics & Outcomes Research (HEOR) Market, by End User – Revenue and Forecast to 2030 (USD Million)

Table 5. Saudi Arabia Health Economics & Outcomes Research (HEOR) Market, by Service – Revenue and Forecast to 2030 (US$ Million)

Table 6. Saudi Arabia: Health Economics & Outcomes Research (HEOR) Market, by Service Provider – Revenue and Forecast to 2030 (USD Million)

Table 7. Saudi Arabia Health Economics & Outcomes Research (HEOR) Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 8. UAE Health Economics & Outcomes Research (HEOR) Market, by Service – Revenue and Forecast to 2030 (US$ Million)

Table 9. UAE: Health Economics & Outcomes Research (HEOR) Market, by Service Provider – Revenue and Forecast to 2030 (USD Million)

Table 10. UAE Health Economics & Outcomes Research (HEOR) Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 11. Qatar Health Economics & Outcomes Research (HEOR) Market, by Service – Revenue and Forecast to 2030 (US$ Million)

Table 12. Qatar: Health Economics & Outcomes Research (HEOR) Market, by Service Provider – Revenue and Forecast to 2030 (USD Million)

Table 13. Qatar Health Economics & Outcomes Research (HEOR) Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 14. Kuwait Health Economics & Outcomes Research (HEOR) Market, by Service – Revenue and Forecast to 2030 (US$ Million)

Table 15. Kuwait: Health Economics & Outcomes Research (HEOR) Market, by Service Provider – Revenue and Forecast to 2030 (USD Million)

Table 16. Kuwait Health Economics & Outcomes Research (HEOR) Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of MEWA Health Economics & Outcomes Research (HEOR) Market, by Service – Revenue and Forecast to 2030 (US$ Million)

Table 18. Rest of MEWA: Health Economics & Outcomes Research (HEOR) Market, by Service Provider – Revenue and Forecast to 2030 (USD Million)

Table 19. Rest of MEWA Health Economics & Outcomes Research (HEOR) Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms

List of Figures

Figure 1. MEWA: PEST Analysis

Figure 2. MEWA Health Economics & Outcomes Research (HEOR) Market - Key Industry Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue Forecast and Analysis – 2020–2030

Figure 5. MEWA Health Economics & Outcomes Research (HEOR) Market Revenue Share, by Service 2022 & 2030 (%)

Figure 6. Clinical Outcome: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 7. Economic Modelling/Evaluation: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 8. Market Access Solutions and Reimbursement: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 9. Real-World Data Analysis and Information Systems: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 10. MEWA Health Economics & Outcomes Research (HEOR) Market Revenue Share, By Service Provider 2022 & 2030 (%)

Figure 11. Contract Research Organizations: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12. Consultancy: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13. MEWA Health Economics & Outcomes Research (HEOR) Market Revenue Share, By End User 2022 & 2030 (%)

Figure 14. Biotech/Pharma Companies: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 15. Healthcare Payers: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 16. Government Organizations: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 17. Healthcare Providers: MEWA Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 18. MEWA: Health Economics & Outcomes Research (HEOR) Market, by Key Country – Revenue (2022) (US$ Million)

Figure 19. MEWA: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (USD Million)

Figure 20. MEWA: Health Economics & Outcomes Research (HEOR) Market, by Country, 2022 & 2030 (%)

Figure 21. Saudi Arabia: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 22. UAE: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23. Qatar: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24. Kuwait: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25. Rest of MEWA: Health Economics & Outcomes Research (HEOR) Market – Revenue and Forecast to 2030 (US$ Million)

The List of Companies - MEWA Health Economics & Outcomes Research(HEOR) Market

  1. PharmaLex GmbH
  2. ICON Plc
  3. IQVIA Holdings Inc
  4. Syneos Health Inc
  5. Optum Inc
  6. Value In Research
  7. ExlService Holdings, Inc
  8. Clarivate Plc
  9. CCHO

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to MEWA Health Economics & Outcomes Research (HEOR) Services Market